California and Nevada are taking steps towards legalizing psychedelics for personal and research purposes. California's Senate committee recently approved a bill introduced by Sen. Scott Wiener to legalize possession and facilitated use of several psychedelic substances derived from plants or fungi, including specific amounts of psilocybin, psilocyn, DMT, ibogaine, and mescaline.

However, synthetic psychedelics like LSD and MDMA would not be legalized. The bill also repeals the state law prohibiting the possession of spores or mycelium capable of producing mushrooms or other material containing psilocybin or psilocyn. Personal possession limits for each substance are also included in the bill.

The legislation also specifically provides for "group counseling and community-based healing" involving the entheogenic substances. While the bill does not include synthetic psychedelics, Sen. Wiener has said that he hopes to address them in the future.

Nevada lawmakers have also introduced a bill to legalize psilocybin and promote research into the psychedelic, as well as encourage studies of MDMA. The legislation would remove criminal and civil penalties for adults who possess, cultivate, or share up to four ounces of psilocybin. Researchers would be able to apply to study psilocybin or MDMA, and studies would focus on the potential mental health applications of the substances.

Both California and Nevada's efforts towards legalizing psychedelics signal a growing interest in exploring the potential therapeutic benefits of these substances. However, it is important to note that these substances can still pose risks, and their use should always be supervised by trained professionals in a controlled setting.